January 2020 in “Journal of Genetics and Gene Therapy” This article discusses the potential use of human hair follicular stem cells combined with platelet-rich plasma for androgenetic alopecia, focusing on the regenerative processes involved, but reports no new clinical results.
January 2020 in “Skinmed” In this study, microneedling combined with platelet-rich plasma led to earlier improvements and high patient satisfaction in a man with androgenic alopecia, compared to microneedling with topical minoxidil.
October 2019 in “International journal of clinical & experimental dermatology” This study found that female pattern hair loss significantly reduces quality of life, particularly among younger patients, those with longer disease duration, and individuals with diagnosed mental health issues.
October 2019 in “International Journal of Research in Dermatology” This study found that combining topical minoxidil with oral spironolactone improved hair loss outcomes in women with female pattern hair loss when compared to minoxidil alone, but benefits plateaued after 6 months.
September 2019 in “Zagazig university medical journal” This study found that topical minoxidil 2% stimulated hair growth in women with female pattern hair loss after 4 months of treatment, though 55% reported side effects like dermatitis and hypertrichosis.
August 2019 in “Journal of Dermatology” This article is a letter to the editor discussing a rare case of Leydig cell tumor with type I diabetes mellitus causing female pattern hair loss, but it contains no abstract or new clinical findings.
July 2019 in “Journal of The American Academy of Dermatology” This article discusses female pattern hair loss and concludes that the utility of lab markers for screening associated conditions remains unclear; no new clinical results are presented.
July 2019 in “Journal of Dermatology and Dermatologic Surgery” This study found no significant link between headcover use and the severity of male-pattern hair loss among adult males, with age being the only associated factor.
April 2019 in “Journal of emerging technologies and innovative research” This article discusses female pattern baldness and effective treatments like oral anti-androgens and topical minoxidil for managing its progression and reversing hair follicle shrinkage, but reports no new findings.
In this study, mesotherapy containing nutritional supplements was found to increase patient satisfaction and improve the number of hair follicles more effectively than topical minoxidil in treating female pattern hair loss, though both methods showed similar overall efficacy in hair density and hair loss reduction.
January 2019 in “Journal of Cosmetics, Dermatological Sciences and Applications” This study reported significant improvements in female pattern hair loss through a combination therapy involving spironolactone, minoxidil, and an injectable treatment over 6 to 12 months, with 95-96% patient satisfaction and minimal complications such as slight pain and hair growth in undesirable areas.
Genetic differences may influence male pattern hair loss in Russians.
December 2018 in “Evidence-Based Practice” Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.
November 2018 in “Biomedical Journal of Scientific and Technical Research” This article discusses the use of PRP and long-acting PRP for treating Female Pattern Hair Loss, emphasizing their potential benefits, but reports no new clinical results.
August 2018 in “Journal of The American Academy of Dermatology” Finasteride helps female-pattern hair loss.
February 2018 in “Medical Hypotheses” This article suggests that male pattern hair loss might have historically served as an evolutionary signal for women to choose younger male partners, potentially improving population fitness.
October 2017 in “Chinese Journal of Dermatology”
Iron and zinc deficiencies may be treated to help female hair loss.
April 2017 in “Journal of Pakistan Association of Dermatology” This study found that female pattern hair loss significantly impacts quality of life, suggesting that psychological support may enhance treatment adherence.
January 2017 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” 60% of women who didn't respond to 5% minoxidil for hair loss showed significant improvement with a 15% minoxidil solution.
December 2016 in “Journal of Pakistan Association of Dermatology” This study found that a combination of systemic cyproterone acetate, ethinyl estradiol, and 5% topical minoxidil significantly improved hair growth and prevented further hair loss in women with female pattern hair loss over six months, with the treatment being well-tolerated.
September 2016 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.
July 2016 in “Biometrics & Biostatistics International Journal” This article discusses the development of the Total View Guidelines for accurately reporting androgenic alopecia treatment effectiveness using uninterrupted video recordings and reports no new clinical results.
May 2016 in “DOAJ (DOAJ: Directory of Open Access Journals)” This study found that vertex accentuation is the second most common pattern of female pattern hair loss in Asian women, following the diffuse type.
In this study, the researchers found no significant link between CAG repeat numbers in the androgen receptor gene and female pattern hair loss in a Chinese population.
Hair transplantation can effectively treat female pattern hair loss if done correctly, considering factors like patient's preferred hairstyle and proper use of techniques and medications.
This study identified vertex accentuation as the second most common pattern of female pattern hair loss in Asian women.
December 2015 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Finasteride, a hair loss treatment, may cause long-term sexual dysfunction and depression.